Verisante Technology, Inc. (VRS) - Product Pipeline Analysis, 2016 Update

Date: June 15, 2016
Pages: 32
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: V49E7091F23EN
Leaflet:

Download PDF Leaflet

Verisante Technology, Inc. (VRS) - Product Pipeline Analysis, 2016 Update
Summary

Verisante Technology, Inc. (Verisante), formerly T-Ray Science, Inc., carries out the development and commercialization of products for the early detection of all forms of skin cancer. The company’s key product offerings include Verisante Aura, Verisante Core and Verisante MSI Camera. The Verisante Aura is used for skin cancer detection, and Verisante Core is used for lung, colon and cervical cancer detection. Verisante MSI Camera is a multispectral imaging camera used in the detection of oral and skin cancer. The cancer detection technology helps the company to develop and offer wide range of compact and non-invasive cancer detection devices. The company is ISO 13485:2003 certified as a medical device manufacturer. Verisante is headquartered in Richmond, British Columbia, Canada.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Verisante Technology, Inc.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Verisante Technology, Inc. Company Snapshot
Verisante Technology, Inc. Company Overview
Verisante Technology, Inc. Pipeline Products and Clinical Trials Overview
Verisante Technology, Inc. – Pipeline Analysis Overview
Business Description
Key Facts
Verisante Technology, Inc. - Major Products and Services
Verisante Technology, Inc. Pipeline Products by Development Stage
Verisante Technology, Inc. Pipeline Products Overview
ClearVu
ClearVu Product Overview
ClearVu Elite
ClearVu Elite Product Overview
Multispectral Imaging (MSI) System
Multispectral Imaging (MSI) System Product Overview
Verisante Aura
Verisante Aura Product Overview
Verisante Core - Cervical Cancer
Verisante Core - Cervical Cancer Product Overview
Verisante Core - Gastro-Intestinal Cancer
Verisante Core - Gastro-Intestinal Cancer Product Overview
Verisante Core - Lung Cancer
Verisante Core - Lung Cancer Product Overview
Verisante Core - Nasopharnygeal Cancer
Verisante Core - Nasopharnygeal Cancer Product Overview
Verisante Technology, Inc. - Key Competitors
Verisante Technology, Inc. - Key Employees
Verisante Technology, Inc. - Key Employee Biographies
Verisante Technology, Inc. - Locations And Subsidiaries
Head Office
Recent Developments
Verisante Technology, Inc., Recent Developments
Dec 21, 2015: Verisante Provides Operational Update
Jul 03, 2015: Verisante Provides Operational Update
Mar 12, 2015: Verisante Obtains Mexican Approval
Feb 18, 2015: Verisante Technology Announces Equipment Loan to Further Collaboration with Key Chinese Laboratory
Oct 01, 2014: Verisante Technology Announces Submission to the FDA for Aura, a Skin Cancer Detection Device
Jul 29, 2014: Verisante Technology Welcomes Dr. Kenneth Beer and Dr. Philip Werschler onto Clinical Advisory Board
Jun 10, 2014: Verisante Technology Partners with the BC Cancer Foundation to Showcase Aura for Skin Cancer Detection
Jun 02, 2014: Verisante Technology, Inc. Announces 2014 First Quarter Results and Provides Operational Update
May 13, 2014: Verisante Technology Announces Milestone Completion of Core Commercial Prototype for the Detection of Lung Cancer
Apr 30, 2014: Verisante Technology Announces 2013 Year End Results and Strategy for Direct Distribution
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Verisante Technology, Inc. Pipeline Products and Clinical Trials Overview
Verisante Technology, Inc. Pipeline Products by Equipment Type
Verisante Technology, Inc. Pipeline Products by Indication
Verisante Technology, Inc., Key Facts
Verisante Technology, Inc., Major Products and Services
Verisante Technology, Inc. Number of Pipeline Products by Development Stage
Verisante Technology, Inc. Pipeline Products Summary by Development Stage
ClearVu - Product Status
ClearVu - Product Description
ClearVu Elite - Product Status
ClearVu Elite - Product Description
Multispectral Imaging (MSI) System - Product Status
Multispectral Imaging (MSI) System - Product Description
Verisante Aura - Product Status
Verisante Aura - Product Description
Verisante Core - Cervical Cancer - Product Status
Verisante Core - Cervical Cancer - Product Description
Verisante Core - Gastro-Intestinal Cancer - Product Status
Verisante Core - Gastro-Intestinal Cancer - Product Description
Verisante Core - Lung Cancer - Product Status
Verisante Core - Lung Cancer - Product Description
Verisante Core - Nasopharnygeal Cancer - Product Status
Verisante Core - Nasopharnygeal Cancer - Product Description
Verisante Technology, Inc., Key Employees
Verisante Technology, Inc., Key Employee Biographies

LIST OF FIGURES

Verisante Technology, Inc. Pipeline Products by Equipment Type
Verisante Technology, Inc. Pipeline Products by Development Stage
Skip to top


Ask Your Question

Verisante Technology, Inc. (VRS) - Product Pipeline Analysis, 2016 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: